BRIACELL THERAPEUTICS CORP. Professional Fees Expense
BRIACELL THERAPEUTICS CORP. (BCTX) reported Professional Fees Expense of $76.63 thousand for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ProfessionalFeesExpense · last filed 2022-06-13
- BRIACELL THERAPEUTICS CORP. professional fees expense for the quarter ending 2022-04-30 was -$21.67K, a 126.49% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. professional fees expense for the quarter ending 2022-01-31 was $79.12K, a 825.72% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. professional fees expense for the quarter ending 2021-07-31 was $15.38K.
- BRIACELL THERAPEUTICS CORP. professional fees expense for the quarter ending 2021-04-30 was $81.81K.
| Period end | Professional Fees Expense 3 month | Professional Fees Expense 6 month | Professional Fees Expense 9 month | Professional Fees Expense 12 month | Professional Fees Expense 13 month |
|---|---|---|---|---|---|
| 2022-04-30 | -$21.67K derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | $57.45K derived: sum of 2 quarters · filed 2022-06-13 | $76.63K 6-K · filed 2022-06-13 | ||
| 2022-01-31 | $79.12K 6-K · filed 2022-03-15 | $98.29K 6-K · filed 2022-03-15 | |||
| 2021-07-31 | $15.38K derived: 40-F/A 12 month − 6-K 9 month · filed 2021-11-16 | $97.18K derived: sum of 2 quarters · filed 2022-06-13 | $105.73K derived: sum of 3 quarters · filed 2022-06-13 | $114.28K 40-F/A · filed 2021-11-16 | |
| 2021-04-30 | $81.81K 6-K · filed 2022-06-13 | $90.35K derived: sum of 2 quarters · filed 2022-06-13 | $98.90K 6-K · filed 2022-06-13 | ||
| 2021-01-31 | $8.55K 6-K · filed 2022-03-15 | $17.09K 6-K · filed 2022-03-15 | |||
| 2020-07-31 | $34.19K 40-F/A · filed 2021-11-16 | ||||
| 2019-08-31 | $34.19K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |